FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely ophthalmology. To perform crosslinking of corneal collagen in keratoconus of stages I or II, de-epithelization is performed in the area of ectasia with a diameter of 4-6 mm. The cornea is saturated with riboflavin solution for 30 minutes and UV radiation is applied to the cornea for 30 minutes with a power of 3 mW/cm2. Throughout the procedure, an anesthetic with benzalkonium chloride is instilled every 5-10 minutes. Exposure to UV radiation is carried out in the 9 mm zone of the cornea.
EFFECT: method reduces the time of epithelization with maximum impact on the pathological area of the cornea by reducing the area of the de-epithelized surface.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CONDUCTING ULTRAVIOLET CORNEAL CROSS-LINKING USING BIOLENS WITH THIN CORNEA | 2020 |
|
RU2739995C1 |
| METHOD FOR ACCELERATED LOCAL CROSSLINKING OF CORNEA IN KERATECTASIA | 2023 |
|
RU2804716C1 |
| DETERMINATION OF DIFFERENTIATED INDICATIONS FOR CHOICE OF THE METHOD OF TREATING KERATOCONUS II-III STAGES | 2015 |
|
RU2596729C1 |
| CORNEAL CROSSLINKING METHOD | 2021 |
|
RU2822101C2 |
| METHOD OF TREATING KERATOCONUS STAGE I-II | 2022 |
|
RU2819801C2 |
| METHOD OF TREATING KERATOCONUS, INCLUDING IN PATIENTS WITH CORNEAL THICKNESS OF LESS THAN 450 MICRONS, USING ULTRAVIOLET CROSS-LINKING OF CORNEAL COLLAGEN IN COMBINATION WITH PERSONALIZED TRANSEPITHELIAL PHOTOREFRACTIVE KERATECTOMY | 2023 |
|
RU2814093C1 |
| METHOD OF TREATMENT OF KERATECTASIA BY THE METHOD OF PULSE ACCELERATED ULTRAVIOLET CROSSLINKING OF CORNEA | 2017 |
|
RU2682494C1 |
| METHOD OF TREATING CORNEAL ECTATIC DISORDERS | 2013 |
|
RU2510258C1 |
| OPHTHALMIC AGENT FOR TRANSEPITHELIAL ULTRAVIOLET CORNEAL COLLAGEN CROSSLINKING | 2014 |
|
RU2560669C1 |
| METHOD FOR DETERMINING DIFFERENTIATED INDICATIONS FOR SELECTING METHOD OF TREATING PROGRESSIVE KERATOCONUS USING FEMTOSECOND LASER | 2018 |
|
RU2694517C1 |
